Cite
Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).
MLA
Wang, Yu, et al. “Polydatin Ameliorates Lipid and Glucose Metabolism in Type 2 Diabetes Mellitus by Downregulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).” Cardiovascular Diabetology, vol. 15, Feb. 2016, p. 19. EBSCOhost, https://doi.org/10.1186/s12933-015-0325-x.
APA
Wang, Y., Ye, J., Li, J., Chen, C., Huang, J., Liu, P., & Huang, H. (2016). Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9). Cardiovascular Diabetology, 15, 19. https://doi.org/10.1186/s12933-015-0325-x
Chicago
Wang, Yu, Jiantao Ye, Jie Li, Cheng Chen, Junying Huang, Peiqing Liu, and Heqing Huang. 2016. “Polydatin Ameliorates Lipid and Glucose Metabolism in Type 2 Diabetes Mellitus by Downregulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).” Cardiovascular Diabetology 15 (February): 19. doi:10.1186/s12933-015-0325-x.